BLOG — Saisei Mirai

  The key concept of cancer therapy is the destruction of local cancer tissue in combination with immunotherapy. It is important that we destroy local cancer tissue with minimal side effects and kill cancer cells selectively. In this meaning, Sondynamic therapy, Ultrasound guided HIFU and Tumor-treating field therapy in combination with GcMAF based Immunotherapy seem to be very promising.

Saisei Mirai has developed the 2nd and 3rd Generation GcMAF in Japan. We hold worldwide patents. We have clinics in Osaka, Kobe, and Tokyo.  Our head office and cell processing center are in Osaka.     We have been mainly treating cancer patients in the past, but we now treat patients with a wide variety of diseases from all over the world.   Saisei Mirai is expanding overseas and now has several branches around the world. Our goal is to help cure serious diseases, such as cancer, autism, and infectious diseases.   Saisei Mirai is conducting joint research with 6 universities...